NYSE:ABC - AmerisourceBergen Stock Price, Price Target & More

$90.58 +0.71 (+0.79 %)

(As of 04/23/2018 09:49 AM ET)

Previous Close$89.87

Today's Range$90.15 - $90.58

52-Week Range$71.90 - $106.27

Volume9,190 shs

Average Volume1.98 million shs

Market Capitalization$19.74 billion

P/E Ratio15.28

Dividend Yield1.66%

Beta1.06

About AmerisourceBergen (NYSE:ABC)

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company's Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; specialty transportation and logistics services for the biopharmaceutical industry; and animal health care products. It markets its products and services through independent sales forces and marketing organizations. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

Receive ABC News and Ratings via Email

Sign-up to receive the latest news and ratings for ABC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries

Sub-IndustryHealth Care Distributors

SectorMedical

SymbolNYSE:ABC

CUSIP03073E10

Webwww.amerisourcebergen.com

Phone610-727-7000

Debt

Debt-to-Equity Ratio1.61%

Current Ratio0.95%

Quick Ratio0.50%

Price-To-Earnings

Trailing P/E Ratio15.28

Forward P/E Ratio13.85

P/E Growth1.36

Sales & Book Value

Annual Sales$153.14 billion

Price / Sales0.13

Cash Flow$8.0301 per share

Price / Cash11.28

Book Value$9.47 per share

Price / Book9.56

Profitability

EPS (Most Recent Fiscal Year)$5.88

Net Income$364.48 million

Net Margins0.66%

Return on Equity53.65%

Return on Assets3.82%

Miscellaneous

Employees20,000

Outstanding Shares219,670,000

How to Become a New Pot Stock Millionaire

AmerisourceBergen (NYSE:ABC) Frequently Asked Questions

What is AmerisourceBergen's stock symbol?

AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?

AmerisourceBergen declared a quarterly dividend on Wednesday, February 7th. Stockholders of record on Tuesday, February 20th will be paid a dividend of $0.38 per share on Monday, March 5th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 1.68%. The ex-dividend date is Friday, February 16th. View AmerisourceBergen's Dividend History.

How were AmerisourceBergen's earnings last quarter?

AmerisourceBergen (NYSE:ABC) issued its quarterly earnings results on Tuesday, February, 6th. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.35 by $0.20. The company earned $40.47 billion during the quarter, compared to analyst estimates of $40.42 billion. AmerisourceBergen had a return on equity of 53.65% and a net margin of 0.66%. The business's revenue for the quarter was up 6.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.36 EPS. View AmerisourceBergen's Earnings History.

When is AmerisourceBergen's next earnings date?

AmerisourceBergen is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for AmerisourceBergen.

What guidance has AmerisourceBergen issued on next quarter's earnings?

AmerisourceBergen issued an update on its FY18 earnings guidance on Tuesday, February, 6th. The company provided earnings per share (EPS) guidance of $6.45-6.65 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.23. The company issued revenue guidance of +8-11% to ~$165.4-170.0 billion, compared to the consensus revenue estimate of $166.65 billion.

What price target have analysts set for ABC?

16 brokers have issued 12 month price targets for AmerisourceBergen's stock. Their predictions range from $87.00 to $115.00. On average, they expect AmerisourceBergen's share price to reach $103.0714 in the next year. View Analyst Ratings for AmerisourceBergen.

Who are some of AmerisourceBergen's key competitors?

Some companies that are related to AmerisourceBergen include Baxter International (BAX), Illumina (ILMN), Takeda Pharmaceutical (TKPYY), Hospital Co. of America (HCA), Regeneron (REGN), Fresenius Medical Care (FMS), Essilor International (ESLOY), Astellas Pharma (ALPMY), McKesson (MCK), Actelion (ALIOF), Shire (SHP), Edwards Lifesciences (EW), Fresenius Medical Care (FME), Alexion Pharmaceuticals (ALXN), Zimmer Biomet (ZBH), Mylan (MYL), Align Technology (ALGN) and Sunny Optical Technology (Group) (SNPTF).

Who are AmerisourceBergen's key executives?

AmerisourceBergen's management team includes the folowing people:

Mr. Steven H. Collis, Chairman, Pres & CEO (Age 57)
Mr. Tim G. Guttman, Exec. VP & CFO (Age 59)
Mr. John G. Chou, Exec. VP and Chief Legal & Bus. Officer (Age 62)
Dr. Robert P. Mauch, Exec. VP and Group Pres of Pharmaceutical Distribution & Strategic Global Sourcing (Age 51)
Mr. James D. Frary, Exec. Officer (Age 46)

Has AmerisourceBergen been receiving favorable news coverage?

Media headlines about ABC stock have trended somewhat positive recently, according to Accern Sentiment Analysis. Accern scores the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. AmerisourceBergen earned a media sentiment score of 0.12 on Accern's scale. They also gave media headlines about the company an impact score of 45.83 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of AmerisourceBergen?

Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AmerisourceBergen's stock price today?

One share of ABC stock can currently be purchased for approximately $90.58.

How big of a company is AmerisourceBergen?

AmerisourceBergen has a market capitalization of $19.74 billion and generates $153.14 billion in revenue each year. The company earns $364.48 million in net income (profit) each year or $5.88 on an earnings per share basis. AmerisourceBergen employs 20,000 workers across the globe.

How can I contact AmerisourceBergen?

AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at 610-727-7000 or via email at [email protected]

MarketBeat Community Rating for AmerisourceBergen (ABC)

Community Ranking:		2.6 out of 5 ( )
Outperform Votes:		478 (Vote Outperform)
Underperform Votes:		433 (Vote Underperform)
Total Votes:		911

MarketBeat's community ratings are surveys of what our community members think about AmerisourceBergen and other stocks. Vote "Outperform" if you believe ABC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABC will underperform the S&P 500 over the long term. You may vote once every thirty days.

AmerisourceBergen (NYSE:ABC) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

16 Wall Street analysts have issued ratings and price targets for AmerisourceBergen in the last 12 months. Their average twelve-month price target is $103.0714, suggesting that the stock has a possible upside of 13.79%. The high price target for ABC is $115.00 and the low price target for ABC is $87.00. There are currently 6 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Hold
Consensus Rating Score:	2.63	2.63	2.57	2.45
Ratings Breakdown:	0 Sell Rating(s) 6 Hold Rating(s) 10 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 6 Hold Rating(s) 10 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 6 Hold Rating(s) 8 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 6 Hold Rating(s) 5 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$103.0714	$103.7857	$96.75	$91.50
Price Target Upside:	13.79% upside	8.56% upside	5.76% downside	11.79% upside

AmerisourceBergen (NYSE:ABC) Consensus Price Target History

Price Target History for AmerisourceBergen (NYSE:ABC)

AmerisourceBergen (NYSE:ABC) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/2/2018	Royal Bank of Canada	Set Price Target	Hold	$101.00	Medium
3/27/2018	Barclays	Lower Price Target	Equal Weight -> Equal Weight	$104.00 -> $95.00	Low
3/5/2018	Argus	Boost Price Target	Buy	$93.96 -> $115.00	Low
2/27/2018	Cowen	Reiterated Rating	Buy	$108.00	Low
2/27/2018	Bank of America	Initiated Coverage	Buy -> Buy	$111.00	High
2/8/2018	Needham & Company LLC	Lower Price Target	Buy -> Buy	$117.00 -> $113.00	Medium
2/7/2018	Jefferies Group	Set Price Target	Hold	$95.00	Medium
2/7/2018	Credit Suisse Group	Reiterated Rating	Outperform -> Outperform	$105.00 -> $112.00	Medium
1/24/2018	Mizuho	Set Price Target	Hold	$100.00	Low
1/4/2018	Evercore ISI	Initiated Coverage	Outperform -> Outperform	$105.00	Medium
1/2/2018	Leerink Swann	Set Price Target	Buy	$90.00 -> $105.00	Low
12/15/2017	Goldman Sachs	Upgrade	Neutral -> Buy		High
12/4/2017	Deutsche Bank	Initiated Coverage	Buy	$97.00	High
12/1/2017	Robert W. Baird	Set Price Target	Buy	$99.00	High
9/14/2017	Morgan Stanley	Downgrade	Overweight -> Equal Weight		High
8/4/2017	UBS	Lower Price Target	Neutral -> Neutral	$94.00 -> $87.00	Low
10/10/2016	Cleveland Research	Downgrade	Buy -> Neutral		N/A
10/4/2016	Avondale Partners	Upgrade	Market Perform -> Outperform		N/A
8/3/2016	Citigroup	Boost Price Target	Buy	$100.00 -> $105.00	N/A
8/3/2016	FBR & Co	Boost Price Target	Mkt Perform	$84.00 -> $90.00	N/A
6/1/2016	Raymond James	Downgrade	Outperform -> Market Perform		N/A

(Data available from 4/23/2016 forward)

AmerisourceBergen (NYSE:ABC) Earnings History and Estimates Chart

Earnings by Quarter for AmerisourceBergen (NYSE:ABC)

AmerisourceBergen (NYSE:ABC) Earnings Estimates

2018 EPS Consensus Estimate: $6.47
2019 EPS Consensus Estimate: $7.19

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	2	$1.34	$1.42	$1.38
Q2 2018	2	$1.82	$1.91	$1.87
Q3 2018	2	$1.49	$1.58	$1.54
Q4 2018	2	$1.65	$1.73	$1.69
Q1 2019	1	$1.69	$1.69	$1.69
Q2 2019	1	$2.15	$2.15	$2.15
Q3 2019	1	$1.60	$1.60	$1.60
Q4 2019	1	$1.75	$1.75	$1.75

AmerisourceBergen (NYSE ABC) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/2/2018		$1.84					N/A
2/6/2018	Q1 2018	$1.35	$1.55	$40.4208 billion	$40.4663 billion	View	Listen
11/2/2017	Q4 2017	$1.32	$1.33	$40.1045 billion	$39.12 billion	View	N/A
8/3/2017	Q3 2017	$1.37	$1.43	$39.1292 billion	$38.7071 billion	View	Listen
5/4/2017	Q2 2017	$1.6790	$1.77	$38.0652 billion	$37.1474 billion	View	Listen
1/31/2017	Q117	$1.23	$1.36	$39.00 billion	$1.89 billion	View	Listen
11/2/2016	Q416	$1.23	$1.30	$37.97 billion	$37.60 billion	View	Listen
8/2/2016	Q316	$1.27	$1.37	$36.57 billion	$36.90 billion	View	Listen
5/5/2016	Q216	$1.59	$1.68	$35.84 billion	$35.70 billion	View	Listen
2/4/2016	Q116	$1.25	$1.27	$36.84 billion	$36.70 billion	View	N/A
10/29/2015	Q415	$1.18	$1.17	$34.62 billion	$35.50 billion	View	Listen
7/23/2015	Q315	$1.15	$1.20	$33.97 billion	$34.20 billion	View	Listen
4/30/2015	Q215	$1.19	$1.45	$32.25 million	$32.70 billion	View	Listen
1/28/2015	Q115	$0.96	$1.14	$31.44 billion	$33.60 billion	View	Listen
10/30/2014	Q414	$1.05	$1.10	$30.78 million	$31.60 million	View	Listen
7/24/2014	Q314	$0.92	$1.01	$29.23 billion	$30.30 billion	View	Listen
4/24/2014	Q214	$1.00	$1.06	$28.42 million	$28.50 million	View	Listen
1/23/2014	Q114	$0.78	$0.80	$27.43 billion	$29.20 billion	View	Listen
10/31/2013	Q413	$0.74	$0.79	$23.80 billion	$24.50 billion	View	Listen
7/24/2013	Q3 2013	$0.75	$0.73	$21.36 billion	$21.90 billion	View	Listen
4/25/2013	Q2 2013	$0.88	$0.87	$21.33 billion	$20.50 billion	View	Listen
1/24/2013	Q1 2013	$0.67	$0.69	$21.69 billion	$21.50 billion	View	Listen
11/1/2012	Q412	$0.68	$0.66	$20.35 billion	$19.50 billion	View	N/A
7/26/2012		$0.69	$0.71			View	N/A
4/26/2012		$0.81	$0.81			View	N/A
1/26/2012		$0.63	$0.62			View	N/A
11/1/2011		$0.61	$0.54			View	N/A
7/28/2011		$0.59	$0.66			View	N/A
4/28/2011		$0.69	$0.7770			View	N/A
2/4/2011		$0.54	$0.57			View	N/A
11/2/2010	Q4 2010	$0.48	$0.50			View	N/A
7/27/2010	Q3 2010	$0.49	$0.52			View	N/A
4/22/2010	Q2 2010	$0.55	$0.63			View	N/A
1/26/2010	Q1 2010	$0.46	$0.52			View	N/A
11/3/2009	Q4 2009	$0.40	$0.44			View	N/A
7/30/2009	Q3 2009	$0.39	$0.42			View	N/A
4/23/2009	Q2 2009	$0.45	$0.47			View	N/A
1/22/2009	Q1 2009	$0.35	$0.36			View	N/A
10/30/2008	Q4 2008	$0.35	$0.36			View	N/A
7/24/2008	Q3 2008	$0.33	$0.37			View	N/A
4/23/2008	Q2 2008	$0.39	$0.41			View	N/A
1/24/2008	Q1 2008	$0.31	$0.31			View	N/A

(Earnings results data provided by Zacks Investment Research)

AmerisourceBergen (NYSE:ABC) Dividend Information

AmerisourceBergen pays an annual dividend of $1.52 per share, with a dividend yield of 1.68%. ABC's most recent quarterly dividend payment was Monday, March 5. The company has grown its dividend for the last 13 consecutive years and is increasing its dividend by an average of 14.00% each year. AmerisourceBergen pays out 25.85% of its earnings out as a dividend.

Most Recent Dividend:	3/5/2018
Annual Dividend:	$1.52
Dividend Yield:	1.68%
Dividend Growth:	14.00% (3 Year Average)
Payout Ratio:	25.85% (Trailing 12 Months of Earnings) 23.24% (Based on This Year's Estimates) 20.79% (Based on Next Year's Estimates)
Track Record:	13 Years of Consecutive Dividend Growth
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for AmerisourceBergen (NYSE:ABC)

AmerisourceBergen (NYSE:ABC) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/7/2018	quarterly	$0.38	1.76%	2/16/2018	2/20/2018	3/5/2018
11/9/2017	quarterly	$0.38	2.03%	11/17/2017	11/20/2017	12/4/2017
8/10/2017	quarterly	$0.3650	1.82%	8/17/2017	8/21/2017	9/5/2017
5/9/2017	quarterly	$0.3650		5/18/2017	5/22/2017	6/5/2017
2/9/2017	quarterly	$0.3650	1.61%	2/16/2017	2/21/2017	3/6/2017
11/10/2016	quarterly	$0.3650	1.85%	11/17/2016	11/21/2016	12/5/2016
8/4/2016	quarterly	$0.34	1.52%	8/18/2016	8/22/2016	9/6/2016
5/10/2016	quarterly	$0.34	1.77%	5/19/2016	5/23/2016	6/6/2016
2/9/2016	quarterly	$0.34	1.59%	2/18/2016	2/22/2016	3/7/2016
11/6/2015	quarterly	$0.34	1.4%	11/12/2015	11/16/2015	12/1/2015
8/6/2015	quarterly	$0.29	1.11%	8/13/2015	8/17/2015	9/1/2015
5/5/2015	quarterly	$0.29	1.02%	5/14/2015	5/18/2015	6/1/2015
2/5/2015	quarterly	$0.29	1.2%	2/12/2015	2/17/2015	3/2/2015
11/3/2014	quarterly	$0.29	1.33%	11/13/2014	11/17/2014	12/1/2014
8/7/2014	quarterly	$0.2350	1.25%	8/14/2014	8/18/2014	9/2/2014
5/9/2014	quarterly	$0.2350	1.43%	5/15/2014	5/19/2014	6/2/2014
2/7/2014	quarterly	$0.2350	1.42%	2/13/2014	2/18/2014	3/3/2014
2/7/2014		$0.2350		2/13/2014	2/18/2014	3/3/2014
11/5/2013	quarterly	$0.2350	1.4%	11/14/2013	11/18/2013	12/2/2013
8/8/2013	quarterly	$0.21	1.41%	8/19/2013	8/21/2013	9/4/2013
5/6/2013	quarterly	$0.21	1.53%	5/16/2013	5/20/2013	6/3/2013
2/4/2013	quarterly	$0.21	1.82%	2/13/2013	2/15/2013	3/4/2013

(Data available from 1/1/2013 forward)

AmerisourceBergen (NYSE ABC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 27.30%
Institutional Ownership Percentage: 66.84%

Insider Trading History for AmerisourceBergen (NYSE:ABC)

Institutional Ownership by Quarter for AmerisourceBergen (NYSE:ABC)

AmerisourceBergen (NYSE ABC) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/17/2018	Robert P Mauch	EVP	Sell	1,000	$90.00	$90,000.00	13,123
4/5/2018	Tim G Guttman	CFO	Sell	11,600	$85.60	$992,960.00	56,472
4/4/2018	Peyton R Howell	Insider	Sell	3,000	$82.72	$248,160.00	49,189
4/2/2018	Dale Danilewitz	Insider	Sell	3,121	$86.10	$268,718.10
4/2/2018	Steven H Collis	Chairman	Sell	21,350	$84.03	$1,794,040.50
3/7/2018	Peyton R Howell	Insider	Sell	3,000	$93.78	$281,340.00	49,189
3/5/2018	Tim G Guttman	CFO	Sell	11,600	$93.01	$1,078,916.00
3/1/2018	Steven H Collis	Chairman	Sell	21,350	$94.25	$2,012,237.50
2/28/2018	Robert P Mauch	Insider	Sell	1,000	$97.94	$97,940.00
2/16/2018	Dale Danilewitz	Insider	Sell	21,500	$97.30	$2,091,950.00
2/13/2018	Richard W Gochnauer	Director	Sell	2,278	$101.13	$230,374.14	13,225
2/7/2018	Peyton R Howell	Insider	Sell	3,000	$91.60	$274,800.00	49,189
2/5/2018	Tim G Guttman	CFO	Sell	11,600	$95.43	$1,106,988.00
2/1/2018	Dale Danilewitz	EVP	Sell	3,121	$97.74	$305,046.54	3,121
2/1/2018	John G Chou	Insider	Sell	15,939	$97.74	$1,557,877.86	67,228
2/1/2018	Steven H Collis	Chairman	Sell	21,350	$98.58	$2,104,683.00	287,925
1/10/2018	Richard W Gochnauer	Director	Sell	2,000	$96.54	$193,080.00	12,947
1/8/2018	Peyton R Howell	Insider	Sell	3,000	$95.11	$285,330.00	49,189
1/3/2018	Tim G Guttman	CFO	Sell	11,600	$93.40	$1,083,440.00
1/2/2018	Dale Danilewitz	Insider	Sell	3,121	$92.12	$287,506.52
1/2/2018	Steven H Collis	Chairman	Sell	21,350	$93.54	$1,997,079.00
12/14/2017	Peyton R Howell	Insider	Sell	17,800	$89.70	$1,596,660.00
12/14/2017	Robert P Mauch	EVP	Sell	3,000	$90.00	$270,000.00	14,531
12/13/2017	Richard W Gochnauer	Director	Sell	2,000	$88.00	$176,000.00	12,947
12/6/2017	Peyton R Howell	Insider	Sell	3,000	$86.20	$258,600.00	49,189
12/4/2017	Tim G Guttman	CFO	Sell	11,600	$85.73	$994,468.00	56,436
12/1/2017	John G Chou	Insider	Sell	15,937	$82.42	$1,313,527.54	67,226
12/1/2017	Steven H Collis	Chairman	Sell	21,350	$82.53	$1,762,015.50	287,925
11/30/2017	Lazarus Krikorian	SVP	Sell	16,427	$84.86	$1,393,995.22	23,360
11/30/2017	Peyton R Howell	EVP	Sell	9,423	$85.80	$808,493.40	57,412
11/29/2017	Richard W Gochnauer	Director	Sell	2,000	$85.00	$170,000.00	12,947
11/20/2017	Dale Danilewitz	Insider	Sell	4,459	$78.30	$349,139.70
11/13/2017	Dale Danilewitz	Insider	Sell	1,857	$74.69	$138,699.33
11/8/2017	Peyton R Howell	EVP	Sell	3,000	$74.87	$224,610.00	38,335
11/6/2017	John G Chou	Insider	Sell	15,937	$74.50	$1,187,306.50	57,924
11/3/2017	Tim G Guttman	CFO	Sell	11,600	$74.28	$861,648.00	40,326
11/2/2017	Dale Danilewitz	Insider	Sell	2,012	$74.99	$150,879.88
11/1/2017	Steven H Collis	Chairman	Sell	21,350	$76.94	$1,642,669.00	260,226
10/5/2017	Dale Danilewitz	Insider	Sell	2,012	$85.00	$171,020.00
10/2/2017	Tim G Guttman	CFO	Sell	11,600	$82.78	$960,248.00
9/25/2017	Peyton R Howell	Insider	Sell	3,243	$80.23	$260,185.89	37,135
9/20/2017	Tim G. Guttman	CFO	Sell	11,600	$79.47	$921,852.00
9/1/2017	Steven H Collis	Chairman	Sell	15,000	$79.92	$1,198,800.00	253,876
8/17/2017	Gina Clark	Insider	Sell	1,273	$80.94	$103,036.62	10,830
8/16/2017	Peyton R Howell	Insider	Sell	20,000	$80.00	$1,600,000.00	57,135
7/3/2017	Steven H Collis	Chairman	Sell	15,000	$94.76	$1,421,400.00	253,876
6/1/2017	Steven H Collis	Chairman	Sell	15,000	$91.73	$1,375,950.00	253,876
5/1/2017	Steven H Collis	Chairman	Sell	15,000	$81.98	$1,229,700.00	253,876
4/3/2017	Steven H Collis	Chairman	Sell	15,000	$88.35	$1,325,250.00	253,876
3/13/2017	Gina Clark	Insider	Sell	12,000	$89.03	$1,068,360.00	12,103
3/3/2017	Lazarus Krikorian	Insider	Sell	9,958	$91.83	$914,443.14	15,743
2/1/2017	Steven H Collis	Chairman	Sell	15,000	$87.15	$1,307,250.00	253,876
12/1/2016	Steven H Collis	Chairman	Sell	15,000	$77.94	$1,169,100.00	238,876
11/1/2016	Steven H Collis	Chairman	Sell	15,000	$69.85	$1,047,750.00	231,252
10/17/2016	Steven H Collis	Chairman	Sell	15,000	$79.59	$1,193,850.00	231,252
9/21/2016	Henry Wadsworth Mcgee III	Director	Sell	3,351	$82.10	$275,117.10	10,901
9/7/2016	Kathy H Gaddes	Insider	Sell	681	$88.15	$60,030.15	1,022
8/31/2016	John G Chou	Insider	Sell	63,750	$85.70	$5,463,375.00	104,043
8/9/2016	Lon R Greenberg	Director	Buy	4,000	$88.59	$354,360.00	9,500
8/5/2016	Gina Clark	Insider	Sell	2,247	$89.50	$201,106.50	9,436
3/1/2016	Dale Danilewitz	EVP	Sell	1,586	$86.80	$137,664.80	2,370
12/21/2015	Steven H. Collis	CEO	Sell	27,148	$102.23	$2,775,340.04	252,204
12/7/2015	Steven H. Collis	CEO	Sell	9,170	$100.06	$917,550.20	243,734
12/4/2015	Steven H. Collis	CEO	Sell	17,978	$100.17	$1,800,856.26	252,204
12/2/2015	Dermot Mark Durcan	Director	Buy	1,000	$99.70	$99,700.00	1,000
11/24/2015	Richard C. Gozon	Director	Sell	8,780	$98.00	$860,440.00	47,776
11/23/2015	Richard C. Gozon	Director	Sell	10,666	$99.00	$1,055,934.00	47,776
11/18/2015	Steven H. Collis	CEO	Sell	25,948	$100.16	$2,598,951.68	252,204
11/16/2015	Dale Danilewitz	EVP	Sell	6,388	$96.86	$618,741.68	3,956
10/27/2015	Steven H. Collis	CEO	Sell	1,200	$100.97	$121,164.00	217,696
9/21/2015	Steven H. Collis	CEO	Sell	27,148	$105.72	$2,870,086.56	217,696
9/15/2015	Henry Wadsworth Mcgee III	Director	Sell	27,592	$105.00	$2,897,160.00	8,253
8/20/2015	Steven H. Collis	CEO	Sell	27,148	$104.27	$2,830,721.96	217,696
8/11/2015	James F Cleary Jr	EVP	Buy	1,000	$104.88	$104,880.00
7/20/2015	Steven H Collis	CEO	Sell	27,148	$114.42	$3,106,274.16
6/23/2015	Gina Clark	EVP	Sell	3,275	$112.36	$367,979.00
6/22/2015	Dale Danilewitz	EVP	Sell	1,712	$112.58	$192,736.96
6/22/2015	Steven H Collis	CEO	Sell	27,148	$112.37	$3,050,620.76
5/22/2015	Dale Danilewitz	EVP	Sell	1,000	$114.03	$114,030.00
5/13/2015	June Barry	EVP	Sell	2,038	$114.36	$233,065.68
5/11/2015	Tim G Guttman	CFO	Sell	16,022	$115.25	$1,846,535.50
5/8/2015	John G Chou	EVP	Sell	78,656	$115.24	$9,064,317.44
5/8/2015	Lazarus Krikorian	SVP	Sell	21,802	$115.35	$2,514,860.70
5/5/2015	Gina Clark	EVP	Sell	1,400	$115.40	$161,560.00
5/4/2015	David W Neu	EVP	Sell	62,971	$115.43	$7,268,742.53
3/20/2015	James Frary	EVP	Sell	73,125	$113.78	$8,320,162.50
3/13/2015	Peyton R Howell	EVP	Sell	45,984	$105.86	$4,867,866.24
3/9/2015	James F Cleary Jr	EVP	Buy	1,000	$102.54	$102,540.00
2/27/2015	Robert P Mauch	EVP	Sell	19,415	$102.79	$1,995,667.85
2/19/2015	Michael J Long	Director	Sell	15,170	$100.61	$1,526,253.70
2/13/2015	David W Neu	EVP	Sell	26,540	$99.45	$2,639,403.00
2/10/2015	Lazarus Krikorian	SVP	Sell	18,000	$96.03	$1,728,540.00
2/6/2015	John G Chou	EVP	Sell	21,460	$97.70	$2,096,642.00
2/4/2015	Steven H Collis	CEO	Sell	145,622	$96.01	$13,981,168.22
1/30/2015	Lon R Greenberg	Director	Buy	3,000	$95.08	$285,240.00
11/4/2014	Henry Wadsworth Mcgee III	Director	Sell	25,109	$87.64	$2,200,552.76
9/15/2014	Richard C Gozon	Director	Sell	18,520	$776.63	$14,383,187.60
9/8/2014	Edward E Hagenlocker	Director	Sell	4,852	$78.09	$378,892.68
6/20/2014	Peyton R Howell	SVP	Sell	45,000	$71.53	$3,218,850.00
6/11/2014	Steven H Collis	CEO	Sell	157,500	$71.83	$11,313,225.00
5/22/2014	John Chou	EVP	Sell	37,500	$71.28	$2,673,000.00	30,649
2/18/2014	Edward Hagenlocker	Director	Sell	13,836	$68.52	$948,042.72	4,852
2/7/2014	Richard Gozon	Director	Sell	19,784	$66.10	$1,307,722.40	43,084
1/6/2014	Henry Wadsworth Mcgee III	Director	Sell	9,449	$69.62	$657,839.38	10,034
11/5/2013	Steven H Collis	CEO	Sell	150,000	$67.20	$10,080,000.00
9/10/2013	James Frary	SVP	Sell	15,000	$59.03	$885,450.00
8/30/2013	John Chou	EVP	Sell	33,518	$56.90	$1,907,174.20	29,685
6/17/2013	Jane E Md Henney	Director	Sell	36,149	$55.16	$1,993,978.84
6/6/2013	David W Neu	SVP	Sell	42,187	$52.95	$2,233,801.65
5/30/2013	Jane E Md Henney	Director	Sell	1,008	$54.53	$54,966.24
5/2/2013	Steven H Collis	CEO	Sell	245,258	$54.41	$13,344,487.78
8/9/2012	David W Neu	SVP	Sell	9,284	$38.84	$360,590.56

(Data available from 1/1/2013 forward)

AmerisourceBergen (NYSE ABC) News Headlines

Source:

Date	Headline
	Robert P. Mauch Sells 1,000 Shares of AmerisourceBergen (ABC) Stock www.americanbankingnews.com - April 18 at 4:10 PM
	AmerisourceBergen (ABC) Stock Rating Reaffirmed by Credit Suisse Group www.americanbankingnews.com - April 18 at 2:58 PM
	How one organization is fighting NC's opioid crisis finance.yahoo.com - April 17 at 5:40 PM
	BidaskClub Lowers AmerisourceBergen (ABC) to Hold www.americanbankingnews.com - April 16 at 7:35 PM
	CNBC: Amazon kills plan to sell drugs to hospitals seekingalpha.com - April 16 at 5:07 PM
	AmerisourceBergen Foundation Donates 55000 Drug Deactivation Resources to Communities Nationwide to Combat ... www.businesswire.com - April 16 at 8:33 AM
	Detailed Research: Economic Perspectives on AmerisourceBergen, Builders FirstSource, Twilio, Gannett Co., Intel, and ... globenewswire.com - April 16 at 8:33 AM
	Detailed Research: Economic Perspectives on AmerisourceBergen, Builders FirstSource, Twilio, Gannett Co., Intel, and Interpace Diagnostics Group — What Drives Growth in Today's Competitive Landscape finance.yahoo.com - April 16 at 8:33 AM
	AmerisourceBergen (ABC) Expected to Announce Quarterly Sales of $40.31 Billion www.americanbankingnews.com - April 14 at 2:54 AM
	Here's Why You Should Steer Clear of AmerisourceBergen Now www.zacks.com - April 13 at 8:46 AM
	Nation's Top Practitioners Address Future of Community Oncology at ION Solutions' LPP National Meeting www.businesswire.com - April 13 at 8:46 AM
	Financial Analysis: Nu Skin Enterprises (NUS) and AmerisourceBergen (ABC) www.americanbankingnews.com - April 13 at 1:07 AM
	AmerisourceBergen (ABC) Given a $90.00 Price Target at Leerink Swann www.americanbankingnews.com - April 13 at 12:25 AM
	Opioid trials to begin in 2019 as settlement is also pushed finance.yahoo.com - April 12 at 5:19 PM
	Zacks: Analysts Anticipate AmerisourceBergen (ABC) Will Announce Earnings of $1.81 Per Share www.americanbankingnews.com - April 12 at 1:29 PM
	AmerisourceBergen (ABC) Rating Lowered to Sell at Zacks Investment Research www.americanbankingnews.com - April 12 at 12:33 PM
	Edited Transcript of ABC presentation 7-Mar-17 1:40pm GMT finance.yahoo.com - April 12 at 9:10 AM
	AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2018 Earnings Release finance.yahoo.com - April 10 at 5:15 PM
	McKesson's Lawsuit Puts PBMs Back Into Harsh Public Spotlight www.thestreet.com - April 9 at 5:06 PM
	McKesson Lawsuit Puts Drug Distributors Back Into Harsh Public Spotlight finance.yahoo.com - April 9 at 5:06 PM
	AmerisourceBergen (ABC) Cut to Sell at Zacks Investment Research www.americanbankingnews.com - April 8 at 10:49 AM
	AmerisourceBergen (ABC) Upgraded to Outperform by Cowen www.americanbankingnews.com - April 7 at 6:04 PM
	AmerisourceBergen (ABC) CFO Sells $992,960.00 in Stock www.americanbankingnews.com - April 6 at 7:14 PM
	Peyton R. Howell Sells 3,000 Shares of AmerisourceBergen (ABC) Stock www.americanbankingnews.com - April 5 at 7:16 PM
	AmerisourceBergen (ABC) Given Average Recommendation of "Buy" by Brokerages www.americanbankingnews.com - April 5 at 3:52 PM
	Jefferies Group Analysts Give AmerisourceBergen (ABC) a $85.00 Price Target www.americanbankingnews.com - April 4 at 4:42 PM
	AmerisourceBergen (ABC) Upgraded to "Buy" by ValuEngine www.americanbankingnews.com - April 4 at 12:02 AM
	Dale Danilewitz Sells 3,121 Shares of AmerisourceBergen (ABC) Stock www.americanbankingnews.com - April 3 at 10:26 PM
	AmerisourceBergen (ABC) Chairman Sells $1,794,040.50 in Stock www.americanbankingnews.com - April 3 at 10:10 PM
	AmerisourceBergen (ABC) Given a $101.00 Price Target at Royal Bank of Canada www.americanbankingnews.com - April 3 at 10:36 AM
	AmerisourceBergen (ABC) PT Set at $105.00 by Leerink Swann www.americanbankingnews.com - March 31 at 12:16 PM
	AmerisourceBergen (ABC) Stock Rating Upgraded by Zacks Investment Research www.americanbankingnews.com - March 30 at 9:28 PM
	Layoffs expected in Rockville as health consulting group shutters local operation www.bizjournals.com - March 28 at 8:48 AM
	AmerisourceBergen (ABC) Price Target Cut to $95.00 by Analysts at Barclays www.americanbankingnews.com - March 27 at 2:22 PM
	Analysts Expect AmerisourceBergen (ABC) to Post $1.81 EPS www.americanbankingnews.com - March 26 at 3:26 PM
	AmerisourceBergen (ABC) Earns "Hold" Rating from Royal Bank of Canada www.americanbankingnews.com - March 25 at 9:30 AM
	AmerisourceBergen (ABC) Now Covered by Analysts at Bank of America www.americanbankingnews.com - March 24 at 9:29 PM
	The AmerisourceBergen Foundation Partners With Jefferson to Address Opioid Crisis www.businesswire.com - March 24 at 5:02 PM
	Head to Head Review: AmerisourceBergen (ABC) and Its Peers www.americanbankingnews.com - March 24 at 11:54 AM
	Patients can’t afford life-saving medications under new health plan change finance.yahoo.com - March 23 at 5:24 PM
	Should Value Investors Pick AmerisourceBergen (ABC) Stock? - Yahoo Finance finance.yahoo.com - March 23 at 8:41 AM
	California issues cease-and-desist order to compounder owned by AmerisourceBergen seekingalpha.com - March 22 at 5:21 PM
	Should Value Investors Pick AmerisourceBergen (ABC) Stock? finance.yahoo.com - March 22 at 5:21 PM
	Trump to release opioid epidemic plan - Seeking Alpha seekingalpha.com - March 21 at 9:22 AM
	Goldman Reiterates Buy On AmerisourceBergen (ABC) After Non Deal Roadshow - StreetInsider.com www.streetinsider.com - March 21 at 9:22 AM
	Zacks Investment Research Lowers AmerisourceBergen (ABC) to Hold www.americanbankingnews.com - March 20 at 6:30 PM
	Here's Why You Should Invest in AmerisourceBergen Right Now finance.yahoo.com - March 16 at 6:11 PM
	Amazon: How It Became Corporate America's 'Nightmare' - Barron's www.barrons.com - March 15 at 8:35 AM
	AmerisourceBergen Corp. (ABC) Receives Average Recommendation of "Buy" from Analysts www.americanbankingnews.com - March 11 at 6:39 PM
	$1.81 Earnings Per Share Expected for AmerisourceBergen Corp. (ABC) This Quarter www.americanbankingnews.com - March 9 at 5:25 PM

AmerisourceBergen (NYSE:ABC) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

AmerisourceBergen (NYSE:ABC) Income Statement, Balance Sheet and Cash Flow Statement

AmerisourceBergen (NYSE ABC) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff